PRESS RELEASE published on 10/10/2024 at 12:22, 2 years ago Closure of IT-IS International Novacyt announces closure of IT-IS International subsidiary to improve EBITDA. Retains IP for ongoing dispute with Roche Diagnostics. Focus on future growth and cost reduction EBITDA Closure Novacyt IT-IS International IP Dispute
BRIEF published on 10/01/2024 at 13:41, 2 years 1 month ago Novacyt Provides Monthly Update on Liquidity Agreement and Total Voting Rights Shareholders Voting Rights Liquidity Agreement INVEST SECURITIES Novacyt
PRESS RELEASE published on 10/01/2024 at 13:36, 2 years 1 month ago Liquidity Agreement Monthly Update and Total Voting Rights Novacyt provides a monthly update on its liquidity agreement with Invest Securities SA and discloses total voting rights. The agreement involves purchasing and selling ordinary shares under French law Liquidity Agreement Total Voting Rights French Law Novacyt Invest Securities SA
BRIEF published on 09/17/2024 at 10:27, 2 years 1 month ago Novacyt Announces HY 2024 Results and Investor Webinar Financial Results Investor Presentation Webinar Diagnostics Novacyt
PRESS RELEASE published on 09/17/2024 at 10:26, 2 years 1 month ago Launch of new website Novacyt S.A. announces the launch of its new website which better reflects the expanded Group following the acquisition of Yourgene Health. Visit novacyt.com for more information Intégration Molecular Diagnostics New Website Novacyt S.A. Yourgene Health
PRESS RELEASE published on 09/17/2024 at 10:22, 2 years 1 month ago Notice of Half Year 2024 Results and Investor Presentation Novacyt S.A. to report half year 2024 results on 26 Sep 2024. Investor webinar scheduled. Novacyt is an international molecular diagnostics company with diverse technologies and services Financial Presentation Half Year Results Molecular Diagnostics Investor Webinar Novacyt S.A.
BRIEF published on 09/06/2024 at 11:51, 2 years 1 month ago Novacyt: Monthly Review of the Liquidity and Voting Rights Agreement Common Shares Voting Rights Liquidity Contract INVEST SECURITIES Novacyt
BRIEF published on 08/22/2024 at 12:52, 2 years 2 months ago Successful VAT recovery for Novacyt Financial Health Regulation Novacyt VAT Recovered DHSC Dispute
BRIEF published on 08/22/2024 at 12:49, 2 years 2 months ago Successful VAT reclaim of £12.2 million by Novacyt Financial Settlement Diagnostics Novacyt VAT Reclaim HMRC
PRESS RELEASE published on 08/22/2024 at 12:44, 2 years 2 months ago Successful VAT reclaim of £12.2 million Novacyt successfully reclaims £12.2 million in VAT from HMRC, increasing net cash position by over £7.0 million. Inside information disclosed Inside Information Novacyt VAT Reclaim Net Cash Position HMRC
Published on 11/02/2026 at 14:00, 4 minutes ago GameSquare to Report Q3 2026 Financial Results on November 16, 2026
Published on 11/02/2026 at 13:30, 34 minutes ago Electric Metals (USA) Limited Announces Results of Annual Meeting of Stockholders
Published on 11/02/2026 at 13:30, 34 minutes ago Predictiv AI Awarded Metrolinx Master Agreement for On-Demand Transit Software and Related Services
Published on 11/02/2026 at 13:00, 1 hour 4 minutes ago International Battery Metals Announces Second Quarter Fiscal 2027 Financial Results Conference Call and Webcast
Published on 11/02/2026 at 13:00, 1 hour 4 minutes ago Bocana Resources Corp. provides an Update on the Proposed Transaction with London Gold LLC
Published on 11/02/2026 at 13:20, 44 minutes ago Westpac 2026 Presentation and Investor Discussion Pack
Published on 11/02/2026 at 13:19, 45 minutes ago Westpac 2026 Full Year Results email to shareholders
Published on 10/30/2026 at 23:00, 2 days 15 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 18:00, 2 days 20 hours ago 2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 3 days 2 hours ago Capital increase through exercise of subscription rights
